Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 12258
TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690482(US12065407, ID CAP01324)
Affinity DataKi:  16nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690482(US12065407, ID CAP01324)
Affinity DataKi:  65nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690462(US12065407, ID CAP01723)
Affinity DataKi:  69nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690478(US12065407, ID CAP01318)
Affinity DataKi:  90nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690483(US12065407, ID CAP01332)
Affinity DataKi:  170nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690457(US12065407, ID CAP01693)
Affinity DataKi:  190nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690481(US12065407, ID CAP01328)
Affinity DataKi:  200nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM63549(cid_2851304 | N,N-dimethyl-4-[(1-methyl-2-benzimid...)
Affinity DataKi:  200nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690462(US12065407, ID CAP01723)
Affinity DataKi:  230nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690484(US12065407, ID CAP01358)
Affinity DataKi:  240nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690481(US12065407, ID CAP01328)
Affinity DataKi:  310nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690470(US12065407, ID CAP01551)
Affinity DataKi:  360nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690471(US12065407, ID CAP01552)
Affinity DataKi:  490nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690477(US12065407, ID CAP01562)
Affinity DataKi:  560nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690450(US12065407, ID CAP01687)
Affinity DataKi:  580nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690475(US12065407, ID CAP01558)
Affinity DataKi:  660nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690469(US12065407, ID CAP01550)
Affinity DataKi:  740nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM63549(cid_2851304 | N,N-dimethyl-4-[(1-methyl-2-benzimid...)
Affinity DataKi:  770nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690461(US12065407, ID CAP01721)
Affinity DataKi:  950nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690476(US12065407, ID CAP01559)
Affinity DataKi:  1.08E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690484(US12065407, ID CAP01358)
Affinity DataKi:  1.10E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690458(US12065407, ID CAP01717)
Affinity DataKi:  1.12E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690478(US12065407, ID CAP01318)
Affinity DataKi:  1.15E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690452(US12065407, ID CAP01689)
Affinity DataKi:  1.16E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690480(US12065407, ID CAP01329)
Affinity DataKi:  1.22E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690446(US12065407, ID CAP01681)
Affinity DataKi:  1.62E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690447(US12065407, ID CAP01684)
Affinity DataKi:  1.66E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690470(US12065407, ID CAP01551)
Affinity DataKi:  1.68E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690474(US12065407, ID CAP01557)
Affinity DataKi:  1.80E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690446(US12065407, ID CAP01681)
Affinity DataKi:  1.88E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690471(US12065407, ID CAP01552)
Affinity DataKi:  1.91E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690480(US12065407, ID CAP01329)
Affinity DataKi:  2.06E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690465(US12065407, ID CAP01540)
Affinity DataKi:  2.20E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690456(US12065407, ID CAP01692)
Affinity DataKi:  2.38E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690447(US12065407, ID CAP01684)
Affinity DataKi:  2.39E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690469(US12065407, ID CAP01550)
Affinity DataKi:  2.40E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690457(US12065407, ID CAP01693)
Affinity DataKi:  2.49E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690444(US12065407, ID CAP01678)
Affinity DataKi:  2.70E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690448(US12065407, ID CAP01685)
Affinity DataKi:  2.70E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690464(US12065407, ID CAP01510)
Affinity DataKi:  2.90E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690476(US12065407, ID CAP01559)
Affinity DataKi:  3.03E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690449(US12065407, ID CAP01686)
Affinity DataKi:  3.17E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690451(US12065407, ID CAP01688)
Affinity DataKi:  3.19E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690450(US12065407, ID CAP01687)
Affinity DataKi:  3.37E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690458(US12065407, ID CAP01717)
Affinity DataKi:  4.04E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690475(US12065407, ID CAP01558)
Affinity DataKi:  4.27E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690453(US12065407, ID CAP01690)
Affinity DataKi:  4.44E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690465(US12065407, ID CAP01540)
Affinity DataKi:  5.50E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690449(US12065407, ID CAP01686)
Affinity DataKi:  6.28E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

TargetM-phase inducer phosphatase 2(Mouse)
Plex Pharmaceuticals

US Patent
LigandPNGBDBM690460(US12065407, ID CAP01720)
Affinity DataKi:  6.34E+3nMAssay Description:Ligand binding was measured by fluorescence polarization of a fluorescein isothiocyanate (FITC) labeled probe (as described by Bollini, et al 2002) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
US Patent

Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: